Clinical Trial

Environmental Influence on Mental Illness Via Modifications of Genomes and Metabolomes in Adolescents With Autism

Study acronym: ENIGMA-I
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 14, 2024 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study is to enrich the understanding of the physiological mechanisms that predispose autistic adolescents to mental illness. It will inform a possible pathway and biomarker handprint of mental illness severity and prognosis to formulate a neurobiologically informed personalization strategy that could be applied for selecting appropriate Evidence Based Intervention (EBI) for treating an adolescent formally diagnosed with Autism.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-06.
Trial Details
NCT Number NCT06299618
Lead Sponsor University College Cork
Collaborators: University of Southampton, Carol Davila University of Medicine and Pharmacy, Microlink PC UK LTE, Engineering Ingegneria Informatica SpA, MEDEA SRL, ORTHOKEY ITALIA SRL
Conditions Autism, Autism Spectrum Disorder
Enrollment 400 participants
Start Date 2024-09
Primary Completion 2025-05 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-08-14